Tang Capital Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.73M | Hold |
5,097,362
| – | – | 0.19% | 96 |
|
|
2025
Q1 | $4.11M | Buy |
5,097,362
+1,447,362
| +40% | +$1.17M | 0.23% | 80 |
|
|
2024
Q4 | $5.04M | Buy |
3,650,000
+1,300,000
| +55% | +$1.79M | 0.33% | 71 |
|
|
2024
Q3 | $2.44M | Buy |
2,350,000
+1,300,000
| +124% | +$1.35M | 0.17% | 93 |
|
|
2024
Q2 | $1.82M | Buy |
+1,050,000
| New | +$1.82M | 0.19% | 80 |
|
|
2023
Q4 | – | Sell |
-400,000
| Closed | -$1.5M | – | 125 |
|
|
2023
Q3 | $1.5M | Hold |
400,000
| – | – | 0.21% | 83 |
|
|
2023
Q2 | $1.71M | Buy |
400,000
+200,000
| +100% | +$854K | 0.25% | 74 |
|
|
2023
Q1 | $1.37M | Buy |
200,000
+84,100
| +73% | +$575K | 0.2% | 75 |
|
|
2022
Q4 | $918K | Sell |
115,900
-634,100
| -85% | -$5.02M | 0.13% | 69 |
|
|
2022
Q3 | $7.21M | Hold |
750,000
| – | – | 0.88% | 34 |
|
|
2022
Q2 | $5.43M | Hold |
750,000
| – | – | 0.82% | 31 |
|
|
2022
Q1 | $9.68M | Buy |
750,000
+100,000
| +15% | +$1.29M | 1.94% | 13 |
|
|
2021
Q4 | $10.4M | Hold |
650,000
| – | – | 2.09% | 13 |
|
|
2021
Q3 | $10.4M | Hold |
650,000
| – | – | 2.17% | 11 |
|
|
2021
Q2 | $8.99M | Hold |
650,000
| – | – | 1.79% | 8 |
|
|
2021
Q1 | $9.5M | Hold |
650,000
| – | – | 2.67% | 7 |
|
|
2020
Q4 | $11.3M | Buy |
650,000
+100,000
| +18% | +$1.74M | 1.72% | 6 |
|
|
2020
Q3 | $10.1M | Hold |
550,000
| – | – | 1.83% | 12 |
|
|
2020
Q2 | $9.82M | Buy |
550,000
+200,000
| +57% | +$3.57M | 0.96% | 14 |
|
|
2020
Q1 | $5.68M | Buy |
+350,000
| New | +$5.68M | 0.8% | 14 |
|